Home > News > Pro-Pharmaceuticals Reports Second Quarter 2006 Results
August 14th, 2006
Pro-Pharmaceuticals Reports Second Quarter 2006 Results
Abstract:
Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel nanotechnology carbohydrate therapeutic compounds, today reported its financial results for the three and six months ended June 30, 2006. For the second quarter of 2006, the Company reported a net loss of $1,184,000, or $0.04 per share ($0.08 fully diluted), compared with a net loss of $1,698,000, or $0.06 per share (basic & fully diluted), for the same period in 2005.
Source:
businesswire
Related News Press |
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||